SPTBN2 Gene

SPTBN2 (Spectrin Beta Non-erythrocytic 2)

Introduction

Sptbn2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

<div class="infobox infobox-gene"> [@clarkson2020]
<table> [@ikeda2019]
<tr><th>Gene Symbol</th><td>SPTBN2</td></tr> [@stankewich2022]
<tr><th>Full Name</th><td>Spectrin Beta Non-erythrocytic 2</td></tr>
<tr><th>Chromosomal Location</th><td>11q13.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[6712](https://www.ncbi.nlm.nih.gov/gene/6712)</td></tr>
<tr><th>OMIM</th><td>[600331](https://www.omim.org/entry/600331)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000173898</td></tr>
<tr><th>UniProt ID</th><td>[O15020](https://www.uniprot.org/uniprot/O15020)</td></tr>
<tr><th>Associated Diseases</th><td>Spinocerebellar Ataxia Type 5 (SCA5)</td></tr>
</table>
</div>

Function

SPTBN2 encodes βIII-spectrin, a critical cytoskeletal protein that stabilizes the plasma membrane and organizes protein complexes in [neurons](/entities/neurons). It is essential for Purkinje cell function and neuronal survival.

SPTBN2 (Spectrin Beta Non-erythrocytic 2)

Introduction

Sptbn2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

<div class="infobox infobox-gene"> [@clarkson2020]
<table> [@ikeda2019]
<tr><th>Gene Symbol</th><td>SPTBN2</td></tr> [@stankewich2022]
<tr><th>Full Name</th><td>Spectrin Beta Non-erythrocytic 2</td></tr>
<tr><th>Chromosomal Location</th><td>11q13.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[6712](https://www.ncbi.nlm.nih.gov/gene/6712)</td></tr>
<tr><th>OMIM</th><td>[600331](https://www.omim.org/entry/600331)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000173898</td></tr>
<tr><th>UniProt ID</th><td>[O15020](https://www.uniprot.org/uniprot/O15020)</td></tr>
<tr><th>Associated Diseases</th><td>Spinocerebellar Ataxia Type 5 (SCA5)</td></tr>
</table>
</div>

Function

SPTBN2 encodes βIII-spectrin, a critical cytoskeletal protein that stabilizes the plasma membrane and organizes protein complexes in [neurons](/entities/neurons). It is essential for Purkinje cell function and neuronal survival.

Structure and Function

• Protein Family: Spectrin family (β-spectrin)
• Molecular weight: ~272 kDa
• Expression: Primarily in neurons, especially cerebellar Purkinje cells
• Cellular localization: Cytoskeleton, plasma membrane

Physiological Role

βIII-spectrin performs critical functions:

• Cytoskeletal stability: Forms meshwork under plasma membrane
• Protein anchoring: Links membrane proteins to actin cytoskeleton
• Organelle trafficking: Facilitates vesicular transport
• Synaptic function: Maintains postsynaptic density architecture

Disease Associations

Spinocerebellar Ataxia Type 5 (SCA5)

Mutations in SPTBN2 cause SCA5, an autosomal dominant ataxia characterized by:

• Pure cerebellar ataxia with slow progression
• Onset typically in adolescence or early adulthood
• Preserved cognitive function
• Lifespan typically normal

• L253P: French founder mutation (St. Louis family)
• ΔETAP: In-frame deletion affecting spectrin repeats
• R480W: Missense mutation in spectrin repeat domain

• Loss of βIII-spectrin function
• Impaired Purkinje cell development
• Dendritic degeneration
• Disrupted synaptic plasticity

Expression

SPTBN2 is highly expressed in:

• Cerebellar Purkinje cells (highest)
• Cerebral [cortex](/brain-regions/cortex) (layers II-III)
• Hippocampal pyramidal neurons
• Basal ganglia neurons
• Peripheral neurons

Therapeutic Targeting

Current approaches:

• Gene therapy: AAV-delivered SPTBN2
• Protein replacement: Exogenous βIII-spectrin delivery
• Neuroprotective agents: Support Purkinje cell survival
• Physical therapy: Maintain motor function

Key Publications

Background

The study of Sptbn2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Spinocerebellar Ataxia](/diseases/spinocerebellar-ataxia) Disease Index
• Cerebellar Degeneration - Mechanism
• Cerebellar Purkinje Cells - Cell Type
• Cytoskeletal Dynamics - Related Pathway

External Links

• [NCBI Gene: SPTBN2](https://www.ncbi.nlm.nih.gov/gene/6712)
• [UniProt: O15020](https://www.uniprot.org/uniprot/O15020)
• [OMIM: 600331](https://www.omim.org/entry/600331)
• [GeneReviews: SPTBN2](https://www.ncbi.nlm.nih.gov/books/NBK1318/)

Clinical Significance

SPTBN2 mutations cause spinocerebellar ataxia type 5 (SCA5):

SCA5 Pathogenesis

• Dominant negative effect on β-III spectrin function
• Disruption of Purkinje cell dendritic architecture
• Impaired synaptic plasticity
• Progressive ataxia and dysarthria

Therapeutic Approaches

• Gene therapy using AAV vectors
• Small molecule stabilizers of β-III spectrin
• Symptomatic treatment for ataxia

Research Directions

Current Research

• Structure-function studies of β-III spectrin domains
• Purkinje cell-specific knock-in models
• High-throughput screening for therapeutic compounds

Model Systems

• Mouse models with SPTBN2 mutations
• Zebrafish morpholino knockdowns
• Patient-derived neuronal cultures

Interactions

Cytoskeletal Proteins

• α-III spectrin: Forms heterodimers
• Ankyrin G: Targets to dendritic membranes
• Actin: Links to cortical cytoskeleton

Signaling Molecules

• GluRδ2: Regulates Purkinje cell synapse formation
• mGluR1: Modulates signaling cascades
• Calbindin: Calcium buffering

Brain Atlas Resources

• [Allen Human Brain Atlas - SPTBN2 Expression](https://human.brain-map.org/microarray/search/show?search_term=SPTBN2)
• [Allen Cell Type Atlas - SPTBN2](https://celltypes.brain-map.org/)
• [BrainSpan - SPTBN2 Developmental Expression](https://brainspan.org/)
• [Allen Mouse Brain Atlas - SPTBN2](https://mouse.brain-map.org/)

References